DR. SHAZAD ASHRAF BUKSH DPM
Prescription History 1942793708
Podiatrist - Foot & Ankle Surgery in Salem, OR

NPI Status: Active since June 07, 2018

Contact Information

1797 TIMBERLINE LN SE
SALEM, OR
ZIP 97306
Phone: (833) 462-2692
Fax: (833) 342-1173

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. SHAZAD ASHRAF BUKSH DPM, an active Foot & Ankle Surgery specialist practicing in Salem, OR. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,407 documented patient claims. Among these therapy options, the most frequently utilized medication is Jublia, which accounts for 1,275 claims alone.

Medication Index

No matching medications currently found on file.

Ciclopirox

Generic Formulation: CiclopiroxSpecialty: Podiatry
Provider Metrics Summary
Total Claims 47
30-Day Fills 47.0
Days Supply 986
OR State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills23.8
Peer Average Days Supply665
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 123.8% higher than the standard regional baseline profile for OR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,036.85 across this reporting matrix range.

Provider Avg Cost Per Claim

$43.34

State Avg Cost Per Claim

$34.78

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane and pyridinone derivative that is used for the treatment of fungal infections of the skin and nails, and for treatment of VAGINAL YEAST INFECTIONS.

Therapeutic Applications

This medication is used to treat fungal infections of the fingernails and toenails. It is used as part of a treatment program that may include the removal of unattached, infected nails by a health care professional. Ciclopirox works by stopping the growth of fungus.

Ciclopirox

Generic Formulation: Ciclopirox OlamineSpecialty: Podiatry
Provider Metrics Summary
Total Claims 61
30-Day Fills 61.0
Days Supply 1,092
OR State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills23.8
Peer Average Days Supply665
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 190.5% higher than the standard regional baseline profile for OR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,880.17 across this reporting matrix range.

Provider Avg Cost Per Claim

$80.00

State Avg Cost Per Claim

$34.78

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane and pyridinone derivative that is used for the treatment of fungal infections of the skin and nails, and for treatment of VAGINAL YEAST INFECTIONS.

Therapeutic Applications

This medication is used to treat fungal infections of the fingernails and toenails. It is used as part of a treatment program that may include the removal of unattached, infected nails by a health care professional. Ciclopirox works by stopping the growth of fungus.

Jublia

Generic Formulation: EfinaconazoleSpecialty: Podiatry
Provider Metrics Summary
Total Claims 1,275
30-Day Fills 1,476.8
Days Supply 38,779
OR State Average Benchmarks
Peer Average Claims54.0
Peer Average 30-Day Fills57.5
Peer Average Days Supply1,314
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 2,261.1% higher than the standard regional baseline profile for OR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,026,051.55 across this reporting matrix range.

Provider Avg Cost Per Claim

$804.75

State Avg Cost Per Claim

$827.65

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat toenail infection caused by fungus. It works by stopping the growth of certain types of fungus. Efinaconazole belongs to a class of drugs known as azole antifungals. This medication treats only fungal infections. It will not work for other types of infection, such as those caused by bacteria. Unnecessary use or overuse of any drug used to treat infection can lead to its decreased effectiveness.

Mupirocin

Generic Formulation: MupirocinSpecialty: Podiatry
Provider Metrics Summary
Total Claims 24
30-Day Fills 24.0
Days Supply 338
OR State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills28.3
Peer Average Days Supply456
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across OR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $351.01 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.63

State Avg Cost Per Claim

$10.63

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.

Therapeutic Applications

Mupirocin is used to treat certain skin infections (such as impetigo). It is an antibiotic. It works by stopping the growth of certain bacteria.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. SHAZAD ASHRAF BUKSH DPM provides transparency into local medical care patterns within Salem, OR.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Foot & Ankle Surgery** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.